World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
33446
World Ranking
1239
National Ranking
108

Miles W. Carroll publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Miles W. Carroll sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 282 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Miles W. Carroll D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Miles W. Carroll sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Miles W. Carroll is a researcher affiliated with the University of Oxford in the United Kingdom. Their academic work primarily focuses on medicine, with a strong emphasis on infectious diseases, epidemiology, molecular biology, animal science and zoology, and immunology.

Their research extensively covers several topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • SARS-CoV-2 detection and testing
  • COVID-19 epidemiological studies

Miles W. Carroll has contributed to multiple publications, with notable recent papers as follows:

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020, The Lancet)
  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera (2021, Cell)
  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2022, Cell)
  • Animal models for COVID-19 (2020, Nature)
  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (2021, Cell)

Their research has appeared frequently in several publication venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • SSRN Electronic Journal
  • Frontiers in Immunology
  • Cell

They have collaborated regularly with a group of co-authors, among the most frequent being:

  • Eleanor Barnes
  • Paul Klenerman
  • Tom Tipton
  • Susanna Dunachie
  • Gavin Screaton

Best Publications

  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Unknown

  • Real-time, portable genome sequencing for Ebola surveillance

    Joshua Quick;Nicholas J. Loman;Sophie Duraffour;Jared T. Simpson;Jared T. Simpson

  • Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

    Ana Maria Henao-Restrepo;Anton Camacho;Ira M. Longini;Conall H. Watson

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

    Joshua Quick;Nathan D Grubaugh;Steven T Pullan;Ingra M Claro

  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

    D Zhou;W Dejnirattisai;P Supasa;C Liu

  • Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

    Ana Maria Henao-Restrepo;Ira M Longini;Matthias Egger;Matthias Egger;Natalie E Dean

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Immunogenicity of a DNA vaccine candidate for COVID-19.

    Trevor R.F. Smith;Ami Patel;Stephanie Ramos;Dustin Elwood

  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

    C Liu;H M Ginn;W Dejnirattisai;P Supasa

  • GP100/PMEL 17 IS A MURINE TUMOR REJECTION ANTIGEN : INDUCTION OF SELF -REACTIVE, TUMORICIDAL T CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND

    Willem W. Overwijk;Allan Tsung;Kari R. Irvine;Maria R. Parkhurst

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Antibody evasion by the P.1 strain of SARS-CoV-2.

    W Dejnirattisai;D Zhou;P Supasa;C Liu

  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

    Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing

  • Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes

    Willem W. Overwijk;David S. Lee;Deborah R. Surman;Kari R. Irvine

  • Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

    J Huo;J Huo;A Le Bas;A Le Bas;R R Ruza;Duyvesteyn Hme.

  • Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

    P Supasa;D Zhou;W Dejnirattisai;C Liu

  • Virus genomes reveal factors that spread and sustained the Ebola epidemic

    Gytis Dudas;Gytis Dudas;Luiz Max Carvalho;Trevor Bedford;Andrew J. Tatem

  • Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

    V M Hirsch;T R Fuerst;G Sutter;M W Carroll

  • Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.

    Andrew D Davidson;Maia Kavanagh Williamson;Sebastian D Lewis;Deborah K Shoemark

  • Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line

    Miles W Carroll;Bernard Moss

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Julian A. Hiscox
Julian A. Hiscox University of Liverpool
Philippa C. Matthews
Philippa C. Matthews University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Juthathip Mongkolsapaya
Juthathip Mongkolsapaya University of Oxford
Susan M. Kingsman
Susan M. Kingsman Oxford BioMedica (United Kingdom)
Derrick W. Crook
Derrick W. Crook University of Oxford
Gavin R. Screaton
Gavin R. Screaton University of Oxford
Stephan Günther
Stephan Günther Bernhard Nocht Institute for Tropical Medicine
Raymond J. Owens
Raymond J. Owens University of Oxford
Alain Townsend
Alain Townsend University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields through online degrees can open valuable career opportunities. Programs such as the easiest fnp program provide a flexible pathway to become a Family Nurse Practitioner, gaining clinical skills that complement immunology knowledge.

Mental health is another critical area connected to immunological research, with growing demand for specialists. The best pmhnp programs online offer strong clinical placement rates, preparing graduates for roles as Psychiatric-Mental Health Nurse Practitioners. Affordability also plays a key role, and prospective students can find quality options like cheap psych np programs that balance cost with comprehensive training.

Graduates often pursue advanced degrees such as the Doctor of Nursing Practice (DNP), which can lead to higher earning potential. Understanding compensation is crucial, and resources like doctor of nursing practice salary provide insights into expected income across different states.

By leveraging these online degree options and exploring career pathways aligned with immunology, students can tailor their education to meet both clinical and research interests, maximizing their impact in healthcare.

Best Scientists Citing Miles W. Carroll

Trending Scientists

Recently Published Articles